Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127065922 | 12706592 | 2 | F | 20160908 | 20160901 | 20160912 | EXP | FR-ROCHE-1822655 | ROCHE | CORTOT A, AUDIGIER-VALETTE C, MOLINIER O, LE MOULEC S, BARLESI F, ZALCMAN G, DUMONT P, POUESSEL D, POULET C, SOUQUET P, HIRET S, DIXMIER A AND RENAULT P-A. WEEKLY PACLITAXEL PLUS BEVACIZUMAB VERSUS DOCETAXEL AS SECOND OR THIRD-LINE TREATMENT IN ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS FROM THE PHASE III STUDY IFCT-1103 ULTIMATE. JOURNAL OF CLINICAL ONCOLOGY 2016 MAY;34 (SUP15):-. | 0.00 | Y | 0.00000 | 20160912 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127065922 | 12706592 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | ON D1 AND 15 | U | 125085 | 10 | MG/KG | SOLUTION FOR INFUSION | ||||||
| 127065922 | 12706592 | 2 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | ON D1, 8 AND 15 | U | 0 | 90 | MG/M**2 | |||||||
| 127065922 | 12706592 | 3 | SS | DOCETAXEL. | DOCETAXEL | 1 | Intravenous (not otherwise specified) | U | 0 | 75 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127065922 | 12706592 | 1 | Non-small cell lung cancer |
| 127065922 | 12706592 | 2 | Non-small cell lung cancer |
| 127065922 | 12706592 | 3 | Non-small cell lung cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127065922 | 12706592 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127065922 | 12706592 | Asthenia | |
| 127065922 | 12706592 | Haemorrhage | |
| 127065922 | 12706592 | Hypertension | |
| 127065922 | 12706592 | Neuropathy peripheral | |
| 127065922 | 12706592 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |